NIH bumps up support for neurological drug development

08/1/2013 | Genetic Engineering & Biotechnology News

The NIH will fund three new projects through its Blueprint Neurotherapeutics Network initiative, under which NIH staff form partnerships with awardee investigators. Sage Therapeutics won funding for Fragile X syndrome drugs, the Scripps Research Institute won an award for nicotine addiction treatments and the University of Utah won funding for drugs to treat age-related macular degeneration.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA